Agenus

Agenus

Yahoo Finance • 11 hours ago

Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus

(RTTNews) - Today's top biotech gainers include Q32 Bio, following positive Phase 2 results for its hair loss treatment; Agenus, as it advances development of its colon cancer drug combination, botensilimab and balstilimab; and Shoulder In... Full story

Yahoo Finance • 20 hours ago

Agenus shares surge as company secures up to $340M to advance colon cancer trial

Agenus shares surge as company secures up to $340M to advance colon cancer trial Proactive uses images sourced from Shutterstock Agenus (Agenus Inc (NASDAQ:AGEN)) shares jumped about 100% on Monday after the biotechnology company announce... Full story

Yahoo Finance • yesterday

Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)

Stock chart with green arrow moving up ©Adobe Stock Images Private Placement Strengthens Funding Position Agenus Inc. (NASDAQ:AGEN) shares climbed 13% in premarket trading on Monday after the biotechnology company announced an $85 millio... Full story

Yahoo Finance • yesterday

Agenus rises premarket; Micron, Western Digital slide

Investing.com - U.S. stock futures were mixed on Monday as investors monitored a sharp selloff across the global memory-chip sector and assessed developments in the biotechnology space. Semiconductor stocks came under broad pressure after... Full story

Yahoo Finance • 28 days ago

Agenus Annual Meeting: BOT/BAL Leads Cancer Drug Push as Balance Sheet Improves

Key Points Interested in Agenus Inc.? Here are five stocks we like better. BOT/BAL remains Agenus' main focus as the company advances botensilimab/balstilimab in hard-to-treat cancers, especially refractory MSS metastatic colorectal cance... Full story

Yahoo Finance • 2 months ago

Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off

[Health Care sector, stock exchange monitor with index information.] Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell... Full story

Yahoo Finance • 4 months ago

Earnings week ahead: FDX, BABA, XPEV, MU, GIS, DOCU, OKLO, ACN, and more

[Quarterly Report Financial Analysis and Business Performance Review with Office Tools] Mohamad Faizal Bin Ramli/iStock via Getty Images Wall Street has entered a quieter phase of the earnings calendar, but the macro environment is shouti... Full story

Yahoo Finance • 7 months ago

Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034) Driven by Increasing Screening Rates and Novel Drug Approvals | DelveInsight

LAS VEGAS, Dec. 1, 2025 /PRNewswire/ -- The colorectal cancer market is growing due to rising incidence driven by aging populations and lifestyle risk factors, which increases demand for screening and treatment. Advances in molecular diagn... Full story

Yahoo Finance • 8 months ago

Agenus reports Q3 results

* Agenus press release [https://seekingalpha.com/pr/20300189-agenus-reports-q3-2025-results-showcasing-clinical-and-regulatory-advances] (AGEN [https://seekingalpha.com/symbol/AGEN]): Q3 GAAP EPS of $1.94. * Revenue of $30.2M (+20.3% Y... Full story

Yahoo Finance • 8 months ago

Earnings week ahead: DIS, CSCO, OXY, PLUG, B, AMAT, JD, BYND, PSKY, and more

[Quarterly report concept.Company financial report.Business charts. Colorful quarter wooden pie chart pieces. Banner with copy space.] Mohamad Faizal Bin Ramli Earnings in the upcoming week will spotlight a diverse lineup across media, te... Full story

Yahoo Finance • 8 months ago

Agenus Q3 2025 Earnings Preview

* Agenus (AGEN [https://seekingalpha.com/symbol/AGEN]) is scheduled to announce Q3 earnings results on Monday, November 10th, before market open. * The consensus EPS Estimate is $2.20 [https://seekingalpha.com/symbol/AGEN/earnings/esti... Full story

Yahoo Finance • 11 months ago

Monday's pre-market session: top gainers and losers

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT E... Full story

Yahoo Finance • last year

Agenus unit, MiNK surges after peer-reviewed data for lead drug

* Shares of MiNK Therapeutics (NASDAQ:INKT [https://seekingalpha.com/symbol/INKT]) climbed over 500% in the morning hours on Friday after the nano-cap cell therapy developer, which is a unit of Agenus (NASDAQ:AGEN [https://seekingalpha.c... Full story

Yahoo Finance • last year

Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL

[Collaboration concept in word tag cloud] rafal_olechowski Agenus (NASDAQ:AGEN [https://seekingalpha.com/symbol/AGEN]) added ~21% in the premarket on Tuesday after the Massachusetts-based biotech announced a partnership with the Indian ph... Full story

Yahoo Finance • 2 years ago

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults Wednesday, GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluat... Full story

Yahoo Finance • 2 years ago

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus In a regulatory filing Friday, Agenus Inc (NASDAQ:AGEN) revealed Bristol Myers Squibb & Co (NYSE:BMY) terminated a license, development, and commercialization agr... Full story

Yahoo Finance • 2 years ago

Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population

Botensilimab/Balstilimab (BOT/BAL) shows major tumor regression in 67.5% of Patients with Localized MSS Colorectal Cancer (CRC), a tumor typically unresponsive to IO therapy The study achieved durable elimination of ctDNA, a critical biom... Full story

Yahoo Finance • 3 years ago

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

growth curve Small-cap stocks have been under pressure ever since the Federal Reserve started hiking interest rates in the first quarter of 2022. As a result, scores of companies in this category sport rock-bottom valuations right now. Wi... Full story

Yahoo Finance • 3 years ago

With 52% institutional ownership, Agenus Inc. (NASDAQ:AGEN) is a favorite amongst the big guns

Key Insights Significantly high institutional ownership implies Agenus' stock price is sensitive to their trading actions A total of 12 investors have a majority stake in the company with 51% ownership Analyst forecasts along with ownersh... Full story

Yahoo Finance • 3 years ago

Agenus to Provide Corporate Update and First Quarter 2023 Financial Report

Conference Call on Tuesday, May 9, 2023 at 8:30 a.m. ET LEXINGTON, Mass., April 25, 2023--(BUSINESS WIRE)--Agenus (Nasdaq: AGEN), a leading immuno-oncology company specializing in immunological agents for cancer and infectious diseases, t... Full story